Photoredox catalysis, peptide therapeutics, biologics, targets, drug discovery, Pharma, Pharma, Bloom, Steve Bloom, The Bloom Group, KU, Science, Peptides, research, unnatural amino acids, peptide libraries, biocompatible photocatalysts, tethering biomolecules, chemotherapeutics, photochemical strategies, fusion proteins, antibody conjugates, bi-specific peptides, light activated molecules, electron oxidation, synthetic radical intermediates, therapeutic scaffolds, medicinally relevant compounds, bio-derived therapeutics, small cell lung cancer, viral capsid, improved therapeutics,

Samuel

Gary

Samuel was raised in West Virginia. He received his B.S. in Biochemistry from West Virginia University where he worked under the tutelage of Dr. Nik Kovinich, researching anticancer natural products. Samuel joined the Bloom lab in 2019 and is currently developing methods for the synthesis of unnatural amino acids and therapeutic peptides.

B.S. - 2019

West Virginia University

Fun facts

  •  Sam’s favorite hobbies of rock climbing and skiing were quickly replaced by “flatter” outdoor activities upon moving to Kansas.
  •  Sam currently has two dogs, a golden retriever and a great dane.
current members
Photoredox catalysis, peptide therapeutics, biologics, targets, drug discovery, Pharma, Pharma, Bloom, Steve Bloom, The Bloom Group, KU, Science, Peptides, research, unnatural amino acids, peptide libraries, biocompatible photocatalysts, tethering biomolecules, chemotherapeutics, photochemical strategies, fusion proteins, antibody conjugates, bi-specific peptides, light activated molecules, electron oxidation, synthetic radical intermediates, therapeutic scaffolds, medicinally relevant compounds, bio-derived therapeutics, small cell lung cancer, viral capsid, improved therapeutics,

INTERDISCIPLINARY SCIENCE BUILDING

1567 Irving Hill road
Lawrence, Kansas 66045

1-410-459-2135

email

Instagram Twitter Youtube Facebook

© 2020 The Bloom Group / All rights reserved 

Site by TriLion